CBSNews.com
/
CBS Evening News
/
CBS This Morning
/
60 Minutes
/
Sunday Morning
/
Face the Nation
/
48 Hours
Markets
Investing
Tech
Leadership
Small Business
Saving
Spending
Retirement
Video
Log In
Log In
Join CBSNews.com
Sign in with
My Profile
Manage my newsletter subscriptions
Update my e-mail address
Change my password
Log Out
Get
Recent Quotes
View Full List
/
Top Indices
Dow Jones Industrials
Nasdaq Composite
S&P 500
NYSE Composite
NYSE MKT Composite
INTERCEPT PHARM
(NQ:
ICPT
)
34.47
USD
UNCHANGED
Official Closing Price
/ Updated:
8:10 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Options
Historical Prices
Chart
Chart
News
All News
Press Releases
Related Stories
Blogs
Podcasts
SEC Filings
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
33.68
Bid (Size)
31.24 (100)
Ask (Size)
37.82 (100)
Prev. Close
34.47
Today's Range
33.68 - 34.50
52wk Range
17.96 - 42.67
Shares Outstanding
16,805,191
Dividend Yield
N/A
Top News
More News
Intercept Pharmaceuticals Announces Positive Initial Results from Ongoing Phase 2a Trial in Chronic Bile Acid Diarrhea
May 20, 2013
from
PR Newswire
3 Hot Biotechs to Keep on Your Radar
May 10, 2013
Read More
category
NASDAQ:MEIP
,
NASDAQ:REGN
,
NASDAQ:ICPT
, and 1 more.
from
InvestorPlace - Latest Headlines
Intercept Pharmaceuticals Announces Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis Presented at EASL
April 30, 2013
Data Support Unmet Therapeutic Need in Primary Biliary Cirrhosis and Strong Statistical Correlation of POISE Phase 3 Primary Endpoint With Clinical Outcomes
Read More
from
GlobeNewswire News Releases
Intercept Pharmaceuticals to Present at Upcoming Healthcare Conferences
April 25, 2013
from
GlobeNewswire News Releases
More News
Read More
UPDATE: Wedbush Raises PT on Intercept Pharmaceuticals on Decreased Regulatory Risk
April 15, 2013
category
Benzinga
,
ICPT
,
Wedbush
, and 3 more.
from
Latest Articles from Benzinga.com
Intercept Pharmaceuticals Announces Upcoming EASL Presentation
April 08, 2013
from
GlobeNewswire News Releases
The Early Investor Bird Does Catch the Worm
March 23, 2013
category
NASDAQ:VASC
,
NASDAQ:MEIP
,
Stock Picks
, and 3 more.
from
InvestorPlace - Latest Headlines
Intercept Pharm (ICPT) Reports Q4 Loss of $2.02
March 18, 2013
from
StreetInsider.com News Articles
Intercept Pharmaceuticals Announces 2012 Financial Results and Provides Business Update
March 18, 2013
from
GlobeNewswire News Releases
Intercept Pharmaceuticals to Host 2012 Fourth Quarter and Full Year Financial Results Conference Call on March 18
March 12, 2013
from
GlobeNewswire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here